Xceleron, the global leader for zeptobiology analysis in the field of drug development, announced today the appointment of Dr. John Holaday to its board of directors. A well-known and respected pioneer in biotechnology, Holaday is the founder of EntreMed, Inc. (ENMD, NASDAQ), and until his retirement in 2003, served as its President, Chief Executive Officer and Chairman of the Board.
